Jim Zhongning Chen Institution Verified

Sourced from institutional research profiles (UAMS TRI or ARA).

Researcher

University of Arkansas for Medical Sciences

faculty

2 h-index 19 pubs 55 cited

Research Areas

Cancer-related molecular mechanisms research Cancer Genomics and Diagnostics Diet and metabolism studies Cancer Treatment and Pharmacology MicroRNA in disease regulation Telemedicine and Telehealth Implementation AI in cancer detection Health and Medical Research Impacts

Links

ORCID Research Group UAMS TRI Profile

Edit your profile

OverviewAI-generated summary

Jim Zhongning Chen's research interests encompass the intersection of cancer biology, clinical oncology, and the development of diagnostic and therapeutic strategies. His recent publications explore the stem cell theory of cancer, examining the clinical implications of cellular metabolism, epigenomic versus genomic biomarkers, and metabolomics. Chen has also investigated predictive factors for adjuvant therapy in colon cancer, utilizing AI-enhanced data pipelines for real-world outcomes in breast cancer treatment, and the administration of bispecific antibodies in community oncology settings. Further work includes the identification of microRNA biomarkers for refractory germ cell tumors and the incidence and outcomes of cutaneous involvement by peripheral T-cell lymphoma. Collaborations at the University of Arkansas for Medical Sciences include shared publications with Alan Baltz, Timothy Langford, and Neriman Gökden.

Metrics

h-index: 2
Publications: 19
Citations: 55

Selected Publications

Role of proliferation-related genes as predictive factors for adjuvant therapy in colon cancer. (2025) DOI
Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021) (2024) DOI
Comparison of Echocardiographically-Calculated Fontan Fenestration Gradient and Catheter-Based Measurement (2024) DOI
Comparison of Echocardiographically-Calculated Fontan Fenestration Gradient and Catheter-Based Measurement (2024) DOI
Abstract 1567: Honing in on the metastasis machinery (2024) DOI
Stem Cell Theory of Cancer: Clinical Implications for Cellular Metabolism and Anti-Cancer Metabolomics (2024) DOI
Identification of a panel of microRNA biomarkers for the management of patients with refractory germ cell tumor of the testis. (2024) DOI
Interdigitating Dendritic Cell Sarcoma and Indeterminate Dendritic Cell Tumor: Patient Characteristics, Prognostic Factors, and Survival Outcomes for Rare Dendritic Cell Neoplasms (2023) DOI
Stem Cell Theory of Cancer: Clinical Implications of Epigenomic versus Genomic Biomarkers in Cancer Care (2023) DOI
Participation in a multidisciplinary institutional committee, “RQUEST,” to enhance quality improvement education, project design, and implementation for hematology/oncology fellows. (2023) DOI
Weight loss (WL) as a predictive factor for immune oncology (IO). (2023) DOI
Bilateral germ cell tumor of the testis (TGCT): Implications for a stem cell versus genetic origin of cancers. (2023) DOI
Origin of extragonadal versus gonadal seminomas. (2023) DOI
Validity of mutations as a cancer chronometer. (2022) DOI